The DOI matches its Crossref record.
The interleukin‐1 family: 10 years of discovery 1
Abstract
Ten years ago the cloning of two interleukin-1 molecules (IL-1 alpha and IL-1 beta) resolved the question of whether a single polypeptide could evoke a wide variety of biological effects. During the past decade, the biology of IL-1 has greatly expanded our understanding of how the host responds to external challenges, such as injury and infection, as well as its role in several diseases. We learned of the remarkable potency of IL-1 in the femtomolar range and of its ability to induce a response by triggering only one or two receptors per cell. Unexpectedly, the IL-1 family of genes, receptors and associated molecules have been linked to those of Drosophila, nematodes, and microorganisms and IL-1 signal transduction is similar to that observed after cellular stress. The cloning of IL-1 opened other avenues of fundamental biological interest. For example, in addition to the two agonist molecules IL-1 alpha and IL-1 beta, a third member of the IL-1 gene family is a specific, high affinity receptor antagonist (IL-1 receptor antagonist). That this third member of the IL-1 family inhibits the other two is characteristic of the tight control over production and activity exerted on IL-1. Although IL-1 contributes to the pathogenesis of many diseases, a small amount appears to be needed to combat infection and initiate healing processes. This article highlights 10 years of discoveries on IL-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL‐1ra inhibits IL‐1β signal transduction (211) and IL‐10 inhibits synthesis of TNF‐α (212).”
From Muscle–Organ Crosstalk: The Emerging Roles of Myokines (2020) · cites this paper as [211]
In the citing paper
“IL-1RA inhibits IL-1β signal transduction126”
From Exerkines in health, resilience and disease (2022) · cites this paper as [126]
Citations
Cited by
Sorted by citations
Items 601–700 of 783
Rivieccio, M. A., Cosenza, M., Brosnan, C. F., Si, Q., & Lee, S. H. (2005) · CRC Press eBooks · doi:10.1201/9781420039849.ch1 · Cited by 7
Ayada, K., Tsuchiya, M., Yoneda, H., et al. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00112 · Cited by 7
Morteza, A., Nakhjavani, M., Ghadiri‐Anari, A., Esteghamati, A., & Khalilzadeh, O. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0282 · Cited by 7
“IL-1 receptor antagonist is a member of the nterleukin-1 cytokine family, which inhibits the activities f IL-1 and modulates a variety of interleukin-1-related mmune and inflammatory responses [46].”
BackgroundLin− Cells Mediate Tissue Repair by Regulating MCP-1/CCL-2
Schatteman, G. C., Awad, O., Nau, E., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091232 · Cited by 7
Marin, M. L., Wong, S.-S., & Pestka, J. J. (1996) · Toxicology · doi:10.1016/s0300-483x(96)03416-6 · Cited by 7
Utal, A. K., Stopka, A. L., & Coleman, P. D. (1998) · Neurochemical Research · doi:10.1023/a:1022493228015 · Cited by 7
Interleukin-1 receptor antagonist gene polymorphism and obesity: A pilot study from north India
Manchanda, P., Bid, H. K., Achyut, B. R., Mittal, B., Srivastava, N., & Mittal, R. D. (2007) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02912883 · Cited by 6
“IL-1Ra is an endogenous inhibitor that antagonizes many of the biological actions of IL-1 by competitive inhibition (11).”
BackgroundGuo, Q., Li, J., Zhong, L., Cai, H., Wang, H.-R., Yan, H., Xia, G., Kang, Y.-M., & Wang, C. (2019) · Molecular human reproduction · doi:10.1093/molehr/gaz058 · Cited by 8
Spang, C., Renström, L., Alfredson, H., & Forsgren, S. (2017) · Europe PMC (PubMed Central) · Cited by 7
NF-κB in Male Reproduction: A Boon or a Bane?
Agarwal, A. (2011) · The Open Reproductive Science Journal · doi:10.2174/1874255601103010085 · Cited by 6
“Interleukin 1 (IL-1) is one among a family of three 17 kDa proteins: IL-1 alpha, beta and IL-1Ra (receptor antagonist) [58].”
BackgroundUse of Antisense Oligonucleotides to Modify Inflammatory Processes
Bennett, C. F., & Condon, T. P. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58785-6_12 · Cited by 6
Falconer-Turner, A., Brooks, K., Ogaga, E. I., & Whalen, M. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4700 · Cited by 5
“…macrophages in the lymphoid organs (spleen, Peyer's patches, thymus, lymph nodes, and bone marrow); and tissue macrophages of non-lymphoid organs (liver, lungs, and digestive tract) (Dinarello, 1994; Kaneko, Kurata, Yamamoto, Morikawa, & Masumoto, 2019; Takács, Kovacs, Smith, Young, & Durum, 1988).”
de Groot, N., Fariñas, F., Cabrera-Gómez, C. G., Pallarés, F. J., & Ramis, G. (2024) · Frontiers in Animal Science · doi:10.3389/fanim.2024.1308514 · Cited by 6
Schizas, N., Perry, S. E., Andersson, B., Wählby, C., Kullander, K., & Hailer, N. P. (2017) · NeuroImmunoModulation · doi:10.1159/000484607 · Cited by 5
Polimorfimos en genes de respuesta inflamatoria en cáncer renal metastásico
Sáenz-López, P., Alonso, F. V., Romero, J. M., Carretero, R., Buñuel, M. T., Ruiz‐Cabello, F., & Olmo, J. M. C. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)74180-4 · Cited by 6
Jamshidi, M., Pour, S. M., & Mahmoudian‐Sani, M. (2020) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s248349 · Cited by 7
Therapeutic applications of cytokines for immunostimulation and immunosuppression: An update
Cardi, G., Ciardelli, T. L., & Ernstoff, M. S. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8998-8_6 · Cited by 5
PMA treatment fosters rat retinal ganglion cell survival via TNF signaling
Ferreira, É. C., Oliveira, A. C. D. R., Garcia, C. G., Cossenza, M., Gonçalves-de-Albuquerque, C. F., Castro-Faria-Neto, H. C., Giestal‐de‐Araujo, E., & dos Santos, A. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136197 · Cited by 4
Participación de la interleucina 1β (IL-1β) en periodontitis
Rivera, L. E. C., Cabrera, S., & Ramos, A. P. (2022) · Revista Odontológica Mexicana Órgano Oficial de la Facultad de Odontología UNAM · doi:10.22201/fo.1870199xp.2007.11.4.83316 · Cited by 4
Altmeier, S., & LeibundGut‐Landmann, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-50842-9_2 · Cited by 5
Stress-Related Blood Biomarkers
Szczepek, A. J., & Mazurek, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-58397-6_6 · Cited by 4
Wang, Q., Wang, D., & Tang, C. (2015) · Europe PMC (PubMed Central) · Cited by 4
Zanetta, J., & Vergoten, G. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0065-0_8 · Cited by 4
Sallam, M. A., Attia, E. A. S., & Soliman, M. M. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1411-0 · Cited by 4
“Both IL-1a and IL-1b are produced by macrophages, monocytes and dendritic cells.”
BackgroundWyroba, E., & Satir, B. H. (2000) · Biochemistry and Cell Biology · doi:10.1139/bcb-78-6-683 · Cited by 4
Glycoproteins: Roles in Cellular Homeostasis and Disease
King, M. W. (2006) · Encyclopedia of Molecular Cell Biology and Molecular Medicine · doi:10.1002/3527600906.mcb.200300040 · Cited by 5
Interleukin 1 (IL-1) Causes Changes in Lateral and Rotational Mobilities of IL-1 Type I Receptors
Guo, C., Georgiadis, K. E., Dower, S., et al. (1999) · Biochemistry · doi:10.1021/bi982068l · Cited by 4
In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-4636(200007)51:1 · Cited by 4
Sauder, D. N., & Dytoc, M. T. (1997) · Current Problems in Dermatology · doi:10.1016/s1040-0486(97)80019-1 · Cited by 4
Inflammation and Wound Healing
Sell, S. (2001) · doi:10.1128/9781555818012.ch3 · Cited by 4
Matsumoto, Y., & Suzuki, K. (2025) · Biomolecules · doi:10.3390/biom15101394 · Cited by 3
“IL-1ra is known to inhibit IL-1 β signal transduction [38], while IL-10 suppresses the synthesis of inflammatory cytokines, such as TNF-α [39].”
Rheumatoid arthritis: immunogenetic factors and immune therapies
Firdous, P., Nissar, K., & Ali, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90250-2.00003-0 · Cited by 3
Hu, H., Wang, T.-Y., Chen, Y., et al. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.02.019 · Cited by 3
Interleukin-1 (IL-1) Immunohistochemistry Assay in Oral Squamous Cell Carcinoma
Kamatani, T. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0928-5_23 · Cited by 3
Electroacupuncture Alleviate Lung Injury of Sepsis Through α7nAChR and NF-κB Signaling Pathway
Shi, X.-X., Du, L., Fan, Z., Su, B., Chen, Y., Fang, Z., & Zhang, X. (2022) · Intensive Care Research · doi:10.1007/s44231-022-00008-1 · Cited by 3
“In the early stage of sepsis, the body releases pro-inflammatory cytokines, such as TNF-α and IL-1β, which cause proinflammatory hyperplasia and systemic inflammatory response syndrome [32].”
BackgroundInfluence of IL‐1R2 polymorphisms on endometrial cancer susceptibility in the Chinese Han population
Wu, J., Zhang, W., Cai, J., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.650 · Cited by 3
“Study found that IL‐1R2 regulates the cell metabolism and the response of immune inflammation induced by many cytokines (Dinarello, 1994).”
BackgroundHurdles and Leaps for Protein Therapeutics
Kozlowski, S., Cherney, B., & Donnelly, R. P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05158.x · Cited by 3
Cytokine release from phytohemagglutinin‐blast triggered by normal human serum
Nishimura, M. (2009) · Transfusion · doi:10.1111/j.1537-2995.2008.02051.x · Cited by 3
“Among these are transforming growth factor (TGF)-b and interleukin-10 (IL-10).(1,2) Interleukin-10 can also inhibit the synthesis of a variety of proinflammatory cytokines produced by macrophages and T-helper Type 1 cells, including interferon-g (IFN-g), IL-2, IL-3, tumor necrosis factor-a (TNF-a), and the granulocyte…”
BackgroundIL-1 receptor type I expression in breast cancer
Knüpfer, H., Stanitz, D., Brauckhoff, M., et al. (2001) · The Breast · doi:10.1054/brst.2000.0269 · Cited by 3
The Immunology of The Host‐Parasite Relationship In the Nasopharynxa
Rynnel-Dagöö, B., LINDBERG, K., SAMULESON, A., et al. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51877.x · Cited by 3
Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
Goonetilleke, U. R., Ward, S. A., & Gordon, S. B. (2009) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2009/214216 · Cited by 3
Physiological Regulation of Bone Metabolism and Estrogen Agonism
García‐Pérez, M. Á. (2006) · Springer eBooks · doi:10.1007/3-540-34742-9_7 · Cited by 3
Takahashi, M., & Ikeda, U. (1996) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.24.1-2_5 · Cited by 3
Stromal-Epithelial Interactions in the Cornea
Wilson, S. E. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5389-2_35 · Cited by 3
Wyroba, E., & Satir, B. H. (2000) · Biochemistry and Cell Biology · doi:10.1139/o00-080 · Cited by 3
Polymorphisms Within the Interleukin-1β Gene Cluster and Preeclampsia
Hefler, L., Tempfer, C. M., & Gregg, A. R. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200105000-00004 · Cited by 3
Einfluß von parakrinen Faktoren auf die embryonale Implantation
Krüssel, J.-S., Bielfeld, P., & Polan, M. L. (1998) · Der Gynäkologe · doi:10.1007/pl00003125 · Cited by 3
Lerner, U. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11202-4 · Cited by 3
Chen, J., Stefanovski, D., Haughan, J. E., Jiang, Z., Soma, L. R., & Robinson, M. A. (2024) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2024.110868 · Cited by 3
Proinflammatory Chemical Signaling: Cytokines
Nagamoto‐Combs, K., & Combs, C. K. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_6 · Cited by 2
Linking Obesity and Pancreatic Cancer
McCall, K. D., Schwartz, A. L., & Schwartz, F. (2014) · InTech eBooks · doi:10.5772/58546 · Cited by 3
“The principle obesity-linked pathways include increases in TNF-α, IL-1, IL-6, IL-8, IL-10 and IL-23 as well as activation of NF-κB and STAT3.”
BackgroundInfluentialBiology of tumor cell invasion: Interplay of cell adhesion and matrix degradation
Heino, J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6 · Cited by 117
Okamoto, Y., Tanaka, M., Miyahara, N., et al. (2009) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20315 · Cited by 2
“Three members of the IL-1 family are known: IL-1a, IL-1b, and an IL-1 receptor antagonist (IL-1Ra).”
BackgroundIkeno, H., Apel, M., Zouboulis, C. C., Luger, T. A., & Böhm, M. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1565-z · Cited by 2
“Of note, IL-1 is primarily secreted by monocytes/macrophages [7] and the reported impact of this cytokine on keratinocyte proliferation is not specific for acroinfundibular keratinocytes.”
BackgroundEffect of regular exercise on leukocyte function in young and middle-aged women
Santos, V. C., Procida, I. R., Zicolau, E. A. A., Hatanaka, E., Borges‐Silva, C. N., Pithon‐Curi, T. C., & Cury‐Boaventura, M. F. (2013) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2013.05.002 · Cited by 2
Effects of IL-1 Receptor-Associated Kinase-4 Gene Silencing on Human Osteoblast-Like Cells
Yang, Z., Huang, B., Zhang, Z., et al. (2012) · Connective Tissue Research · doi:10.3109/03008207.2012.694927 · Cited by 2
“Of these, IL-1 is a pleiotropic cytokine and relevant to the induction of a variety of inflammatory cytokines [24].”
BackgroundInflammation: a common pathway in cardiovascular diseases
Libby, P. (2003) · Cited by 2
Gaafar, T., Bayoumi, F. S., El-Senousy, W. M., et al. (2013) · Cited by 2
Modulation of Opioid Analgesic Reward by Inflammatory Agents
Hymel, K. A., Paris, J. J., & McLaughlin, J. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00055-x · Cited by 2
Raitala, A., Hurme, M., Pessi, T., & Eklund, C. (2006) · CRC Press eBooks · doi:10.1201/9781420005325.ch7 · Cited by 2
Hammerich, L., & Tacke, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00011-4 · Cited by 2
Gray‐Owen, S. D., Dehio, C., Rudel, T., Naumann, M., & Meyer, T. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012304220-0/50013-3 · Cited by 2
Chapter 4. Emerging Opportunities in Neuroinflammatory Mechanisms of Neurodegeneration
Shiosaki, K., & Puttfarcken, P. S. (1995) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60917-3 · Cited by 2
Colostrum: Its Health Benefits
Marchbank, T., & Playford, R. J. (2014) · Wiley eBooks · doi:10.1002/9781118635056.ch3 · Cited by 3
Derman, S. G., Kol, S., Ben‐Shlomo, I., et al. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600415 · Cited by 2
BUSCA DE MARCADORES INFLAMATÓRIOS IL-1β, IL-6 e TNF α EM TRABALHADORES EXPOSTOS A POEIRAS MINERAIS
de Castro, A. (2000) · Americanae (AECID Library) · Cited by 2
Liburt, N. R. (2011) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3q81cr5 · Cited by 2
Interleukin 1 Family [F5 to F10]
Kumar, S. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50034-x · Cited by 2
The inflammasome and IL-1β: implications for the treatment of inflammatory diseases
Satoh, T. K., Otsuka, A., Contassot, E., et al. (2015) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-115353 · Cited by 1
Interleukin-1 (IL-1) Immunohistochemistry Assay in Oral Squamous Cell Carcinoma
Kamatani, T. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0247-8_5 · Cited by 1
Ajebli, M., Amssayef, A., Sabiri, M., et al. (2025) · Plants · doi:10.3390/plants14111606 · Cited by 1
“These cytokines are produced by mononuclear leukocytes in response to various stimuli, including endotoxins and lipopolysaccharides [79].”
Gorczynski, L. Y., Terzıoğlu, E., Waelli, T., & Gorczynski, R. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-69146-6_7 · Cited by 1
Effects of Egg Yolk Antibodies on Weanling Pigs Challenged with Pathogenic Salmonella Typhimurium
Rattanatabtimtong, S. (2007) · Cited by 1
Toll-Like Receptors as Novel Therapeutic Targets for the Treatment of Pancreatic Cancer
Kelly, D., Benencia, F., Leonard, D., Malgor, R., Schwartz, A., & Frank, L. (2012) · InTech eBooks · doi:10.5772/27263 · Cited by 2
The Older Rheumatoid Arthritis Patients: Who are They and How Should They Be Treated?
Ranganath, V. K., Amjadi, S., Melikterminas, E., & Fürst, D. E. (2010) · Aging Health · doi:10.2217/ahe.10.62 · Cited by 1
Recombinant proteins and genomics in cancer therapy
Mehta, K., Ozpolat, B., Gohil, K., & Aggarwal, B. (2009) · Springer eBooks · doi:10.1007/978-90-481-2289-9_4
Pathogenetic Changes: Isolated Extremity Trauma and Polytrauma
van Griensven, M. (2010) · Springer eBooks · doi:10.1007/978-0-387-89508-6_3 · Cited by 1
“Mainly IL-1b is involved in inflammatory processes [62, 63].”
BackgroundInterleukin-1 and Implantation
Kruessel, J. S., Hirchenhain, J., Schanz, A., Hess, A. P., Huang, H.-Y., Simón, C., & Polan, M. L. (2007) · Springer eBooks · doi:10.1007/0-387-34944-8_23 · Cited by 1
Recombinant Organisms as Source of Cancer Biotherapeutics
Mehta, K., & Aggarwal, B. B. (1998) · Springer eBooks · doi:10.1007/978-94-009-0029-5_4 · Cited by 1
Lee, S., Seo, I.-B., Son, J.-B., et al. (2009) · The Korea Journal of Herbology · Cited by 1
Inflammatory Cytokines as Targets for Epilepsy Drug Therapy
López‐Meraz, M. L., Medel‐Matus, J., & Niquet, J. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-6355-3_1 · Cited by 1
Interleukin-1 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00002-6 · Cited by 1
Cytokines during the human immunodeficiency virus infection type 1(HIV-1)
Selimova, L. M., Kalnina, L. B., Serebrovskaya, L. V., et al. (2016) · Problems of Virology · doi:10.18821/0507-4088-2016-61-1-39-41 · Cited by 1
“Существенная роль в регуляции иммунного ответа и воспаления принадлежит ИЛ-1β, являющемуся фактором врожденной цепи иммунитета [7].”
Potency of nano-zinc oxide on caspase-3 of male quail exposed to lipopolysaccharide
Maty, H. N., Hameed, H. M., & Hassan, A. A. (2023) · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences · doi:10.33899/ijvs.2023.141585.3121 · Cited by 1
“Septicemia frequently exhibits decreased serum testosterone levels and elevated plasma IL-1 concentrations (8).”
Havas, F., Cohen, M., Krispin, S., & Attia, J. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901031 · Cited by 5
Pozsgai, G., Liang, L., & Brain, S. D. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_8 · Cited by 1
Differences of plasma IL-1 and TNF-α in healthy Chinese Population
Yuan, J., Wang, L., Lin, Y., Chen, J., & Hu, J. (2015) · Open Medicine · doi:10.1515/med-2015-0044 · Cited by 2
Zaleska, M., & Olszewski, W. L. (2021) · Springer eBooks · doi:10.1007/978-981-16-3484-0_14 · Cited by 1
Role of adipokines in the pathophysiology of coronary artery disease
Kumari, R., Kumar, S., Vyavahare, S. S., Srivastava, R., & Srivastava, S. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99521-4.00021-0 · Cited by 1
Nessler, J. N., & Tipold, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284010 · Cited by 3
“It is an antagonist of the proinflammatory cytokines IL-1α and IL-1β by competitive antagonization of the IL-1 receptor [49, 50].”
BackgroundHarmankaya, N. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Pollmächer, T., Schuld, A., & Hinze‐Selch, D. (2003) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4615-0323-1_15 · Cited by 1
Marioni, R. E. (2010) · ERA · Cited by 1
Neurotoxicity of Manufactured Nanoparticles
Hatcher-Martin, J. M., Jones, D. P., Miller, G. W., & Pennell, K. D. (2008) · Wiley eBooks · doi:10.1002/9780470396612.ch16 · Cited by 1
Schizas, N. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Author Response to Comment on “Power of Rare Diseases: Found in Translation”
Fishman, M. C. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008809 · Cited by 1
Docrat, A. (2008) · ResearchSpace (University of KwaZulu-Natal) · Cited by 1
The Control of Pain in Peripheral Tissue by Cytokines and Neuropeptides
Stein, C., & Schäfer, M. (1998) · Cytokines · doi:10.1201/9781420048193.ch18 · Cited by 1
Interleukin 1β inhibits interleukin 6–mediated rat γ fibrinogen gene expression
Zhang, Z., & Fuller, G. M. (2000) · Blood · doi:10.1182/blood.v96.10.3466.h8003466_3466_3472 · Cited by 1
Cytokines in Astroglial Cells: Functions and Mechanisms of Action
Molina‐Holgado, F., Molina‐Holgado, E., Lledó, A., & Guaza, C. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5737-1_11
Metadata
- Authors
- Dinarello, C. A.
- Affiliations
- Tufts University (US)
- Corresponding author
- Dinarello, Charles A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1994-12
- Volume
- 8
- Issue
- 15
- Pages
- 1314-1325
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1514081838
- Cited by
- 783
- References
- 0
- Citations by year
- 2025: 8 · 2024: 8 · 2023: 8 · 2022: 14 · 2021: 17 · 2020: 21 · 2019: 14 · 2018: 11 · 2017: 19 · 2016: 17 · 2015: 23 · 2014: 27 · 2013: 23 · 2012: 26
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI‑15614)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- interleukin-1, IL-1α, IL-1β, interleukin-1 receptor antagonist, IL-1 receptor, Drosophila, nematodes, microorganisms, host response to infection, host response to injury, pathogenesis, cytokine regulation
- MeSH terms
- Animals, Humans, Interleukin-1, Structure-Activity Relationship, Signal Transduction, Receptors, Interleukin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review